We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current SDGCF market cap is 3.36B. The company's latest EPS is JPY 215.3921 and P/E is 0.13.
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Revenue | 588.07B | 617.77B | 634.31B | 648.73B | 690.46B |
| Operating Income | 34.89B | 34.49B | 37.12B | 33.94B | 36.91B |
| Net Income | 23.93B | 23.69B | 25.33B | 23.85B | 25.7B |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Total Assets | 262.2B | 284.28B | 308.53B | 325.77B | 360.67B |
| Total Liabilities | 91.14B | 97.45B | 103.37B | 105.18B | 124.34B |
| Total Equity | 171.06B | 186.82B | 205.16B | 220.59B | 236.33B |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
| Operating | 31.09B | 32.27B | 31.76B | 31.68B | 37.38B |
| Investing | -13.62B | -13.95B | -17.9B | -20.66B | -28.51B |
| Financing | -7.71B | -7.86B | -8.06B | -8.19B | -17.33B |
| Market Cap | 3.36B |
| Price to Earnings Ratio | 0.13 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.04 |
| Price to Book Ratio | 0.01 |
| Dividend Yield | - |
| Shares Outstanding | 119.33M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 300 |
| 52 Week Change | 0.00% |
| 52 Week High | 28.18 |
| 52 Week Low | 28.18 |
| Spread (Intraday) | 30.26 (60.21%) |
| Company Name | Sundrug Co Ltd (PK) |
| Address |
1-38-1 wakamatsu-cho fuchu, hiroshima 183-0005 |
| Website | https://www.sundrug.co.jp |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
